Pharma: Other News To Note

 Boehringer Ingelheim Pharmaceuticals Inc., of Ridgefield, Conn., part of Boehringer IngelheimGmbH, said a new perspective from the FDA stated the agency has not changed its recommendations regarding Pradaxa (dabigatran etexilate mesylate) capsules, following the November 2012 Mini-Sentinel evaluations.